Mount Sinai Morningside at IDWeek 2026

Oct 21–24, 2026 Washington, DC ~12k attendees Website

Mount Sinai Morningside brings 4 presentations to IDWeek 2026 in Washington. Its program centres on antibiotic dosing and stewardship, with work on HIV care. It covers prolonged versus intermittent piperacillin-tazobactam infusion in critically ill adults, single-dose amikacin for drug-resistant cystitis, and a risk score that predicts loss of viral suppression.

OrganizationIDWeek 2026 Attendance
Poster
Thu Oct 22
12:15pm–1:30pm
A Predictive Risk Score for Loss of Viral Suppression at a Midwestern Clinic
Virtual presentation
J2. Medical Records & Informatics
Poster
Thu Oct 22
12:15pm–1:30pm
Prolonged vs Intermittent Piperacillin-Tazobactam Infusion in Critically Ill Adults: A Meta-Analysis of Randomized Trials
Poster Hall B-C · Poster P-50
A2. PK/PD studies
Poster
Fri Oct 23
12:15pm–1:30pm
Single-dose Amikacin for Multidrug-Resistant Gram-negative Cystitis: Does Educating Providers Improve Hospital Outcomes?
Virtual presentation
S2. Antimicrobial Stewardship outcomes assessment (clinical and economic)
Poster
Sat Oct 24
12:15pm–1:30pm
A 48-Year-Old Man With HIV and Progressive Proctocolitis
Poster Hall B-C · Poster P-2152
Fungal infections

Explore the full IDWeek 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Washington. Leave your work email and we’ll be in touch.

Privacy

Download the full IDWeek 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Mount Sinai Morningside

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction